ReviewThe Lancet. Haematology2021
Harnessing the benefits of available targeted therapies in acute myeloid leukaemia.
Hagop Kantarjian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it
ReviewThe Lancet. Haematology2021
Hagop Kantarjian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.